Related Experiment Video
Updated: Jul 14, 2026

Ferromagnetic Bare Metal Stent for Endothelial Cell Capture and Retention
Published on: September 18, 2015
The search for endothelium friendly stents
1Strathclyde Institute of Pharmacy and Biomedical Sciences University of Strathclyde, Glasgow, UK. christopher.mccormick@strath.ac.uk
Concerns about late-stent thrombosis with drug-eluting stents necessitate new stent designs. Understanding thrombosis mechanisms informs the development of next-generation stents with improved drug actions.
Area of Science:
- Cardiovascular science
- Biomedical engineering
- Pharmacology
Background:
- Late-stent thrombosis is a serious complication associated with drug-eluting stents.
- This complication drives the need for innovative stent designs and therapeutic strategies.
Purpose of the Study:
- To examine alternative approaches to drug-eluting stent design.
- To outline the biological mechanisms underlying stent thrombosis.
- To provide a framework for developing next-generation stents.
Main Methods:
- Review of existing literature on drug-eluting stent thrombosis.
- Analysis of biological mechanisms contributing to stent thrombosis.
- Conceptual framework development for future stent design.
Main Results:
- Identification of key biological pathways involved in late-stent thrombosis.
- Understanding of how stent design influences thrombotic events.
- Framework for evaluating drug actions critical for next-generation stents.
Conclusions:
- Next-generation stents require a deeper understanding of thrombosis biology.
- Targeted drug actions are essential to mitigate thrombosis risks.
- Innovative stent designs are crucial for improving patient outcomes.
More Related Videos
06:55Fabrication of Small Caliber Stent-grafts Using Electrospinning and Balloon Expandable Bare Metal Stents
Published on: October 26, 2016
11:49Autologous Endothelial Progenitor Cell-Seeding Technology and Biocompatibility Testing For Cardiovascular Devices in Large Animal Model
Published on: September 9, 2011